Azilsartan is an angiotensin II receptor antagonist. It may provide a beneficial effect on the mechanisms involved in cardiometabolic disease and insulin sensitizing in cells. Diabetic mice treated with azilsartan had lowered expressions of pro-inflammatory cytokines in brain vessels and lowered diabetes-induced BBB permeability.
Uniformity of Dosage Units
Allschoolabs
Uniformity of Dosage Units is a specialised analytical laboratory service that assesses whether individual dosage units contain sufficiently consis...



































